Stock Track | Celestica Soars 5.08% as Analysts Boost Price Targets on Strong Earnings and Outlook

Stock Track
Oct 29

Celestica (CLS) shares are soaring 5.08% in Wednesday's pre-market trading session, following a wave of analyst price target increases in response to the company's strong quarterly results and optimistic future guidance. The electronics manufacturing services provider has impressed Wall Street with its performance, particularly in its hyperscaler business segment.

Multiple financial institutions have significantly raised their price targets for Celestica. RBC Capital Markets increased its target to $400 from $315, maintaining an Outperform rating. Analyst Paul Treiber noted, "Celestica reported another strong quarterly beat and raise," highlighting the company's "momentum with hyperscalers continues to surprise to the upside." Similarly, Barclays raised its target to $357 from $220, Stifel to $385 from $230, and UBS to $350 from $208, among others.

The bullish sentiment is driven by Celestica's impressive growth prospects, with analysts pointing to sustained growth above 25%, further margin expansion, and the company's shift towards higher quality business segments. The initial fiscal year 2026 guidance has exceeded market expectations, solidifying investor confidence in Celestica's long-term potential. As the company continues to strengthen its position in the electronics manufacturing services sector, particularly with hyperscale customers, the market is responding positively to its evolving business model and growth trajectory.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10